Clinical Trial Update: Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial [Phase 2]

View source ↗

Summary

A Phase 2 decentralized clinical trial assessing enasidenib for patients with clonal cytopenia of undetermined significance (CCUS) and IDH2 mutations; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clonal Cytopenia of Undetermined Significance

Drugs mentioned

• Enasidenib (enasidenib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Clonal Cytopenia of Undetermined Significance, CCUS Clonal Cytopenia of Undetermined Significance | Phase 2 | Status: RECRUITING